DekaBank Deutsche Girozentrale’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Hold |
140,000
| – | – | ﹤0.01% | 801 |
|
|
2025
Q1 | $1.34M | Hold |
140,000
| – | – | ﹤0.01% | 799 |
|
|
2024
Q4 | $1.27M | Hold |
140,000
| – | – | ﹤0.01% | 828 |
|
|
2024
Q3 | $1.34M | Hold |
140,000
| – | – | ﹤0.01% | 833 |
|
|
2024
Q2 | $1.34M | Hold |
140,000
| – | – | ﹤0.01% | 831 |
|
|
2024
Q1 | $1.34M | Hold |
140,000
| – | – | ﹤0.01% | 821 |
|
|
2023
Q4 | $462K | Buy |
+140,000
| New | +$462K | ﹤0.01% | 1055 |
|
|
2023
Q2 | – | Sell |
-30,000
| Closed | -$327K | – | 1258 |
|
|
2023
Q1 | $327K | Hold |
30,000
| – | – | ﹤0.01% | 1110 |
|
|
2022
Q4 | $438K | Hold |
30,000
| – | – | ﹤0.01% | 1066 |
|
|
2022
Q3 | $565K | Buy |
30,000
+16,000
| +114% | +$301K | ﹤0.01% | 1016 |
|
|
2022
Q2 | $310K | Hold |
14,000
| – | – | ﹤0.01% | 1114 |
|
|
2022
Q1 | $262K | Buy |
14,000
+1,300
| +10% | +$24.3K | ﹤0.01% | 1164 |
|
|
2021
Q4 | $260K | Buy |
12,700
+300
| +2% | +$6.14K | ﹤0.01% | 1225 |
|
|
2021
Q3 | $280K | Hold |
12,400
| – | – | ﹤0.01% | 1144 |
|
|
2021
Q2 | $320K | Hold |
12,400
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q1 | $334K | Hold |
12,400
| – | – | ﹤0.01% | 1094 |
|
|
2020
Q4 | $358K | Buy |
+12,400
| New | +$358K | ﹤0.01% | 1091 |
|